Arcturus Therapeutics shares underperformed the S&P 500 this year, based on events of August 12, 2025.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Arcturus Therapeutics shares underperformed the S&P 500 this year, based on events of August 12, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Arcturus Therapeutics announced its financial results from San Diego.Sub-event
Arcturus Therapeutics shares underperformed the S&P 500 this year.1 source
Keep exploring
The entities involved
-
Arcturus Therapeutics
biotech company
Related events
Coverage
Newest first; wire copies grouped- ZacksArcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $1